Selvarangan Ponnazhagan, Ph.D., Professor, Department of Pathology, and Senior Scientist in Experimental Cancer Therapeutics, O'Neal Comprehensive Cancer Center, has secured two grants at the year's end for his cancer research.

The first is a two-year, $250,000 2020 METAvivor Breast Cancer Metastatic Society Translational Research Award grant. The title of the grant is, "Co-targeting immunosuppression and skeletal pathology for metastatic breast cancer therapy." METAvivor is a Metastatic Breast Cancer Awareness, Research and Support organization. 

The second is a grant from the Mike Slive Foundation for Prostate Cancer Research, for his grant proposal, "Targeting the androgen receptor axis affects macrophage polarization in castration-resistant prostate cancer." The grant is a $50,000 award funded for the 2020-2021 grant cycle.